Andrea Denker is Professor of "Accelerator Physics for Medicine"
Prof. Dr. Andrea Denker is the head of the department "Proton Therapy" at HZB. © HZB/ M. Setzpfandt
The Beuth Hochschule für Technik Berlin and the Helmholtz-Zentrum Berlin (HZB) have appointed Prof. Dr. Andrea Denker to the joint professorship "Accelerator Physics for Medicine" as of October 1, 2018. Since 2006, Andrea Denker is head of the department "Proton Therapy" at the HZB, which operates the accelerator for eye tumor therapy. The therapy, offered in cooperation with the Charité - Universitätsmedizin Berlin and the HZB, is unique in Germany.
As part of her professorship, Andrea Denker is taking on lectures in the "Physical Technology - Medical Physics" course at Beuth University. In the current winter semester she offers the lecture "Atomic and Nuclear Physics" for Bachelor students.
Even before her appointment, Andrea Denker was a lecturer at the university. "I enjoy this job very much and the contact with the students is very enriching for me and my team at HZB," says Denker. The appointment now creates an even closer connection to the university. "We are already looking forward to many interesting theses that will be written at the proton accelerator at the HZB.
Andrea Denker studied and received her doctorate in physics at the University of Stuttgart. Then she worked at the CSNSM (Centre de Sciences Nucléaires et de Sciences de la Matière) in Orsay, France. In 1995 Andrea Denker started as a scientist at the ion accelerator ISL. Among other things, she calculated and developed the beam parameters for eye tumor therapy, which was launched 20 years ago.
- Disorder creates new properties in compound semiconductorsAn international research team has demonstrated that the intrinsic disorder of the compound semiconductor CuInSnS₄ can be exploited to influence its optical properties. While the atomic vibrations also sense the local disorder, their response is averaged over many different local environments and therefore appear isotropic, as expected for a cubic crystal. In contrast, the optical excitations, known as excitons, are much more sensitive to the local arrangement of atoms. Surprisingly, they show a direction-dependent optical response even though the average crystal structure is cubic. These findings shed new light on the relationship between disorder and material properties, opening up new options for targeted 'disorder engineering' in optoelectronic and photocatalytic devices.
- Superconducting TES array X-ray spectrometer goes into operation at BESSY IIEurope's first and only TES-spectrometer at a synchrotron source is now in operation at BESSY II, developed within a collaboration between the HZB, the MPI-CEC (Mühlheim-an-der-Ruhr, Germany) and the NIST (Boulder CO, USA). The photon detection efficiency of the new instrument exceeds that of wavelength-dispersive X-ray emission spectrometers by a factor of 100 to 1000. It will be used to investigate the electronic properties of atomically thin layers, nanostructures and highly diluted atomic and molecular samples. The team is looking forward to receiving exciting research proposals from the user community.
- A New Era in Catalysis: ASCEND Launch in Berlin, €30 Million in FundingOn 11 June 2026, the Helmholtz-Zentrum Berlin (HZB) in Adlershof hosted the launch of ASCEND (Accelerated Solutions for Catalysis using Emerging Nanotechnology and Digital Innovation). The event took place in the presence of the Minister of Research, Dorothee Bär, President of the Helmholtz Association, Prof. Dr. Martin Keller, and President of the Max Planck Society, Prof. Dr. Patrick Cramer. Bringing together leading partners from industry and research, ASCEND is supported by BMFTR with €30 million in funding and officially started on 1 April 2026. The initiative aims to accelerate the discovery of next-generation catalysts and enable more sustainable chemical processes.